Development of a competitive lateral flow assay utilizing affinity-engineered receptor binding domain (ligand) and human angiotensin-converting enzyme 2 (receptor) for broad-spectrum detection on Betacoronavirus
Biosensors and Bioelectronics · 2026-11 · 311 · 118909
DOI: 10.1016/j.bios.2026.118909 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026-11. Verfasst von Lin Jiang und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Swine and Poultry Breeding Industry, Agro-biological Gene Research Center, Guangdong Academy of Agricultural Sciences, Guangz…. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Biosensing Techniques. Die Arbeit nennt 57 Literaturangaben. Gefördert von: State Administration of Foreign Experts Affairs, Guangdong Provincial Natural Science Foundation.
Abstract (Originalsprache)
Novel infectious Betacoronaviruses are a threat to global public health; therefore, rapid broad-spectrum screening methods are required. However, traditional antibody-dependent lateral flow assay (LFA) is used to detect known viruses based on specific immune recognition. To ensure the robust detection of various Betacoronaviruses species with potential infection risk, we developed a competitive LFA system using the receptor binding domain (RBD) of SARS-CoV-2 spike protein as capture ligand and human angiotensin-converting enzyme 2 (hACE2) as receptor probe. Colloidal gold particles were used to label hACE2, and RBDs with binding activity were successfully expressed in Komagataella phaffii and purified. Considering the functional roles of the residues 498 and 501 of RBD in binding, several single and double mutations were introduced. Molecular docking and microscale thermophoresis were used to investigate the effect of these mutations; among them, Q498Y showed significantly enhanced binding affinity to hACE2. Subsequent specificity and sensitivity analyses demonstrated that the optimized assay employing the Q498Y RBD achieved a limit of detection of 1.66 μg/mL for the SARS-CoV-2 S1 protein. Additionally, cross-recognition of other Betacoronaviruses, such as civet-originated SARS-CoV and bat-originated RshSTT182/200 coronavirus, were effectively detected. This platform provides a proof-of-concept for the receptor-ligand-based detection of Betacoronaviruses with a contagious risk. It may be useful in point-of-care testing, customs quarantine processes, and in-field surveys.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Swine and Poultry Breeding Industry, Agro-biological Gene Research Center, Guangdong Academy of Agricultural Sciences, Guangzhou, Guangdong, 501640, China; College of Animal Science, South China…
- State Key Laboratory of Swine and Poultry Breeding Industry, Agro-biological Gene Research Center, Guangdong Academy of Agricultural Sciences, Guangzhou, Guangdong, 501640, China.
- Institute of Biotechnology, CICVyA, National Institute of Agricultural Technology, Hurlingham, Buenos Aires, Argentina; Instituto de Agrobiotecnología y Biología Molecular, (IABIMO), INTA-CONICET, Argentina.
- College of Animal Science, South China Agricultural University, Guangzhou, Guangdong, 510642, China.
- Institute of Biotechnology, CICVyA, National Institute of Agricultural Technology, Hurlingham, Buenos Aires, Argentina.
- State Key Laboratory of Swine and Poultry Breeding Industry, Agro-biological Gene Research Center, Guangdong Academy of Agricultural Sciences, Guangzhou, Guangdong, 501640, China. Electronic address: beijinlong@gdaas.cn.
Förderung
- State Administration of Foreign Experts Affairs
- Guangdong Provincial Natural Science Foundation
Zitieren
APA
Jiang, L., Wang, S., Wei, W., Bigi, F., Xi, Q., Zhang, X., Zhang, Q., Xu, Q., Ye, S., Gong, X., Li, S., Blanco, F. C., Larzábal, M., Cataldi, Á. A., & Bei, J. (2026). Development of a competitive lateral flow assay utilizing affinity-engineered receptor binding domain (ligand) and human angiotensin-converting enzyme 2 (receptor) for broad-spectrum detection on Betacoronavirus. Biosensors and Bioelectronics, 311, 118909. https://doi.org/10.1016/j.bios.2026.118909
Vancouver
Jiang L, Wang S, Wei W, Bigi F, Xi Q, Zhang X, et al. Development of a competitive lateral flow assay utilizing affinity-engineered receptor binding domain (ligand) and human angiotensin-converting enzyme 2 (receptor) for broad-spectrum detection on Betacoronavirus. Biosensors and Bioelectronics. 2026;311:118909. doi:10.1016/j.bios.2026.118909
BibTeX
@article{Jiang2026,
author = {Jiang, Lin and Wang, Sen and Wei, Wenkang and Bigi, Fabiana and Xi, Qianyun and Zhang, Xiaoai and Zhang, Qi and Xu, Qiuhao and Ye, Shanshan and Gong, Xi and Li, Shihong and Blanco, Federico Carlos and Larzábal, Mariano and Cataldi, Ángel Adrián and Bei, Jinlong},
title = {Development of a competitive lateral flow assay utilizing affinity-engineered receptor binding domain (ligand) and human angiotensin-converting enzyme 2 (receptor) for broad-spectrum detection on Betacoronavirus},
journal = {Biosensors and Bioelectronics},
year = {2026},
volume = {311},
pages = {118909},
doi = {10.1016/j.bios.2026.118909}
}
EUVIMED